Clinical trial · Interventional
Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
Improving Health-Related Quality of Life Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
NCT06982066CI-TRIAL-00093636recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adolescent and Young Adult Cancer | — | UNRESOLVED | — |
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ReSPECT | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- ReSPECT
- description
- Aims 2 and 3 involve a single-arm cohort study of the ReSPECT intervention using a pre-post design. Enrolled participants will complete a survey at baseline, immediately after intervention use, and at 2 months from study enrollment. All participants will also be invited to participate in a brief interview immediately after intervention use.
- interventionNames
- Behavioral: ReSPECT
Primary outcomes (4)
- measure
- Feasibility of implementing the ReSPECT intervention.
- timeFrame
- 2 months
- description
- Feasibility will be based on patient recruitment and completion of the intervention. The intervention will be considered feasible if AYA recruitment is greater than or equal to 60% and if greater than or equal to 80% of consented AYAs complete the intervention (retention). Intervention completion will be defined as AYA completion of the pre-visit questionnaire and post-intervention survey.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria Adolescent and Young Adult Oncology Patients In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Be aged 15-25 years old at time of enrollment. 2. Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following: 1. Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy. 2. Radiotherapy: any radiotherapy to treat the cancer diagnosis. 3. Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery. 3. Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later. 4. Be able to speak and read English 5. Have permission to participate from a member of the patient's primary oncology team. 6. Provision to sign and date the consent/assent form. 7. Active study participation of primary oncology clinician 8. Patient must have primary oncology care at Connecticut Children's Center for Cancer \& Blood Disorders of Children's Hospital Los Angeles Cancer \& Blood Disease Institute Exclusion Criteria An individual who meets and of the following criteria will be excluded from participation in this study: 1. Not currently on cancer-directed therapy. 2. Unable to speak and read English. 3. Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team) Pediatric Oncology Clinicians 1\. Be a pediatric oncology physician, clinical fellow, or advanced practice provider (including nurse practitioners and physician assistants) that provides clinical care for AYA patients with cancer
References
Publications (0)
Data not yet available
No reference posted for this study.